U.S. Department of Health and Human Services / Medical Board of California / World Health Organization / Administration of Subcutaneous Depo / Office on Women / Medical Board / Food and Drug Administration office of Women / Board of Pharmacy / the American College / American Congress / FDA / California Pharmacists Association / Administration of Subcutaneous Depot Medroxyprogesterone Acetate / Division of Reproductive Health / Board of Pharmacy Initial Statement of Reasons / BOARD OF PHARMACY INITIAL STATEMENT OF REASONS Hearing Date / Centers for Disease Control and Prevention / /
Person
Sharon Cohen / Ashley Sweet / Nicole J. Monastersky Maderas / Sharon T. Cameron / Rebekah L. Williams / /
Position
Governor / pharmacist / /
Product
Medroxyprogesterone Acetate / Provera / Medical Board / /
1 BOARD OF PHARMACY INITIAL STATEMENT OF REASONS Hearing Date: No hearing is presently planned unless one is requested no later than 15 days before the close of the 45-day comment period. Subject Matter of Proposed Regul